Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Apr;93(4):994–1004. doi: 10.1111/j.1476-5381.1988.tb11490.x

Pressor responses induced by Bay K 8644 involve both release of adrenal catecholamines and calcium channel activation.

S Moreland 1, M P Ushay 1, S D Kimball 1, J R Powell 1, R S Moreland 1
PMCID: PMC1853869  PMID: 2455580

Abstract

1. The dihydropyridine calcium channel activator, Bay K 8644, is believed to increase mean arterial blood pressure in several animal models, as a result of direct activation of vascular smooth muscle cells by increasing calcium influx through the voltage-dependent calcium channels. The purpose of the current study was to elucidate further the mechanism of action of Bay K 8644, by examining the possibility that the pressor response to Bay K 8644 may also be the result of indirect activation of the vascular smooth muscle cells by release of adrenal catecholamines. 2. Intravenous administration of Bay K 8644 increased mean arterial pressure in a dose-dependent manner in conscious, normotensive rats. This pressor response was blocked by calcium channel blockers (nifedipine, verapamil, and diltiazem) at doses lower than were necessary to decrease resting mean arterial pressure. 3. alpha-Adrenoceptor antagonists (phentolamine, yohimbine, and prazosin) completely blocked the Bay K 8644-induced pressor responses and converted them to depressor responses. Adrenalectomy did not alter the inhibitory effect of phentolamine on the pressor response to Bay K 8644. However, adrenalectomy or adrenal demedullectomy prevented the phentolamine-induced reversal of the Bay K 8644 pressor response to a depressor response. In addition, adrenalectomy did not affect the ability of phentolamine to reverse the pressor response to exogenous adrenaline administration to a depressor response. 4. These data suggest that the pressor response to Bay K 8644 may involve both direct activation of vascular smooth muscle cells and indirect activation of the muscle cells by release of adrenal catecholamines.

Full text

PDF
994

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen S. L., Foster R. W., Small R. C., Towart R. The effects of the dihydropyridine Bay K 8644 in guinea-pig isolated trachealis. Br J Pharmacol. 1985 Sep;86(1):171–180. doi: 10.1111/j.1476-5381.1985.tb09447.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bolton T. B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev. 1979 Jul;59(3):606–718. doi: 10.1152/physrev.1979.59.3.606. [DOI] [PubMed] [Google Scholar]
  3. Brown A. M., Kunze D. L., Yatani A. The agonist effect of dihydropyridines on Ca channels. Nature. 1984 Oct 11;311(5986):570–572. doi: 10.1038/311570a0. [DOI] [PubMed] [Google Scholar]
  4. Ceña V., García A. G., Khoyi M. A., Salaices M., Sanchez-García P. Effect of the dihydropyridine Bay K 8644 on the release of [3H]-noradrenaline from the rat isolated vas deferens. Br J Pharmacol. 1985 Jul;85(3):691–696. doi: 10.1111/j.1476-5381.1985.tb10565.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dong Y. J., Wadsworth R. M. Effects of Bay K 8644 on 45Ca uptake and efflux and on contraction in the rabbit aorta. Br J Pharmacol. 1986 Jan;87(1):139–145. doi: 10.1111/j.1476-5381.1986.tb10165.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Droogmans G., Callewaert G. Ca2+-channel current and its modification by the dihydropyridine agonist BAY k 8644 in isolated smooth muscle cells. Pflugers Arch. 1986 Mar;406(3):259–265. doi: 10.1007/BF00640911. [DOI] [PubMed] [Google Scholar]
  7. Ehrlich B. E., Schen C. R., Garcia M. L., Kaczorowski G. J. Incorporation of calcium channels from cardiac sarcolemmal membrane vesicles into planar lipid bilayers. Proc Natl Acad Sci U S A. 1986 Jan;83(1):193–197. doi: 10.1073/pnas.83.1.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977;17:149–166. doi: 10.1146/annurev.pa.17.040177.001053. [DOI] [PubMed] [Google Scholar]
  9. Freedman S. B., Miller R. J. Calcium channel activation: a different type of drug action. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5580–5583. doi: 10.1073/pnas.81.17.5580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gross R., Kayser M., Schramm M., Taniel R., Thomas G. Cardiovascular effects of the calcium-agonistic dihydropyridine BAY K 8644 in conscious dogs. Arch Int Pharmacodyn Ther. 1985 Oct;277(2):203–216. [PubMed] [Google Scholar]
  11. Hess P., Lansman J. B., Tsien R. W. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature. 1984 Oct 11;311(5986):538–544. doi: 10.1038/311538a0. [DOI] [PubMed] [Google Scholar]
  12. Hwang K. S., Van Breemen C. Effects of the Ca agonist Bay K8644 on 45Ca influx and net Ca uptake into rabbit aortic smooth muscle. Eur J Pharmacol. 1985 Oct 22;116(3):299–305. doi: 10.1016/0014-2999(85)90166-9. [DOI] [PubMed] [Google Scholar]
  13. Lefer A. M., Whitney C. C., 3rd, Hock C. E. Mechanism of the pressor effect of the calcium agonist, BAY k 8644, in the intact rat. Pharmacology. 1986;32(4):181–189. doi: 10.1159/000138168. [DOI] [PubMed] [Google Scholar]
  14. Montiel C., Artalejo A. R., García A. G. Effects of the novel dihydropyridine BAY-K-8644 on adrenomedullary catecholamine release evoked by calcium reintroduction. Biochem Biophys Res Commun. 1984 May 16;120(3):851–857. doi: 10.1016/s0006-291x(84)80185-0. [DOI] [PubMed] [Google Scholar]
  15. Moreland S., Moreland R. S. Effects of dihydropyridines on stress, myosin phosphorylation, and V0 in smooth muscle. Am J Physiol. 1987 Jun;252(6 Pt 2):H1049–H1058. doi: 10.1152/ajpheart.1987.252.6.H1049. [DOI] [PubMed] [Google Scholar]
  16. Preuss K. C., Brooks H. L., Gross G. J., Warltier D. C. Positive inotropic actions of the calcium channel stimulator, Bay k 8644, in awake, unsedated dogs. Basic Res Cardiol. 1985 May-Jun;80(3):326–332. doi: 10.1007/BF01907908. [DOI] [PubMed] [Google Scholar]
  17. Schramm M., Thomas G., Towart R., Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature. 1983 Jun 9;303(5917):535–537. doi: 10.1038/303535a0. [DOI] [PubMed] [Google Scholar]
  18. Somlyo A. V., Somlyo A. P. Electromechanical and pharmacomechanical coupling in vascular smooth muscle. J Pharmacol Exp Ther. 1968 Jan;159(1):129–145. [PubMed] [Google Scholar]
  19. WEEKS J. R., JONES J. A. Routine direct measurement of arterial pressure in unanesthetized rats. Proc Soc Exp Biol Med. 1960 Aug-Sep;104:646–648. doi: 10.3181/00379727-104-25937. [DOI] [PubMed] [Google Scholar]
  20. Wahler G. M., Sperelakis N. New Ca2+ agonist (Bay K 8644) enhances and induces cardiac slow action potentials. Am J Physiol. 1984 Aug;247(2 Pt 2):H337–H340. doi: 10.1152/ajpheart.1984.247.2.H337. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES